Drug archive
Aldesleukin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
- Biological response modifier
Description
Aldesleukin (al-des-LOO-kin) is a synthetic (man-made) version of a substance called interleukin-2. Interleukins are produced naturally by cells in the body to help white blood cells work. Aldesleukin is used to treat cancer of the kidney and skin cancer that has spread to other parts of the body.
Aldesleukin causes some other very serious effects in addition to its helpful effects. Some effects can be fatal. For that reason, aldesleukin is given only in the hospital. If severe side effects occur, which is common, treatment in an intensive care unit (ICU) may be necessary. Other effects may not be serious but may cause concern. Before you begin treatment with aldesleukin, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Aldesleukin is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:
- Injection (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Proleukin
Other commonly used names are interleukin-2 and IL-2 .
† Not commercially available in Canada.